Buys
Open market- Shares
- Avg price
- Total value
Bernard Coulie - President and CEO, Director at PLIANT THERAPEUTICS, INC.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- President and CEO, Director
- Issuer Symbol
- PLRX on Nasdaq
- All Insider Reports
- All Insider Reports
Bernard Coulie - trading volume in the past year for PLIANT THERAPEUTICS, INC.
Sells
Open market- Shares
- -89,375
- Avg price
- $1.28
- Total value
- -$114,400
Net
Past year- Shares
- -89,375
- Share %
- -100%
- Total value
- -$114,400
Holdings reported by Bernard Coulie for PLIANT THERAPEUTICS, INC.
Form 4 holding
President and CEO, Director
PLIANT THERAPEUTICS, INC.
- Security class
- Common Stock
- Shares / value
- 505,601
- Estimated value
- $647,169
- Report date
- 20 Jan 2026
- Price
- $1.28
- Ownership
- Direct
Form 4 holding
President and CEO, Director
PLIANT THERAPEUTICS, INC.
- Security class
- Common Stock
- Shares / value
- 409,317
- Estimated value
- $499,366
- Report date
- 20 Jan 2026
- Price
- $1.22
- Ownership
- Indirect
Form 4 holding
President and CEO, Director
PLIANT THERAPEUTICS, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 325,000
- Estimated value
- Report date
- 17 Apr 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by Bernard Coulie for PLIANT THERAPEUTICS, INC.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.